ethanolamine has been researched along with Disease Models, Animal in 11 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "3% w/v (weight of solute per volume of solution) monoethanolamine (MEA) into his lungs, causing asthma-like symptoms." | 3.75 | Effects of inhaled monoethanolamine on bronchoconstriction. ( Hayashi, I; Ide, A; Kamijo, Y; Majima, M; Soma, K; Yoshimura, K, 2009) |
| "Diabetic peripheral neuropathy (DPN), diabetic kidney disease (DKD), and diabetic retinopathy (DR) contribute to significant morbidity and mortality in diabetes patients." | 1.51 | Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes. ( Abcouwer, SF; Backus, C; Brosius, FC; Feldman, EL; Hayes, JM; Hinder, LM; Kayampilly, P; Lin, CM; O'Brien, PD; Pennathur, S; Rumora, AE; Sas, KM; Shanmugam, S; Zhang, H, 2019) |
| "Pre-treatment with ethanolamine decreased infarct size in isolated mouse or rat hearts subjected to I/R but this infarct sparing effect was lost in cardiomyocyte specific STAT-3 deficient mice." | 1.36 | Ethanolamine is a novel STAT-3 dependent cardioprotective agent. ( Hacking, D; Kelly, RF; Lacerda, L; Lamont, KT; Lecour, S; Opie, LH; Somers, S; Thomas, P, 2010) |
| "Ethanolamine oleate (ETH) is a sclerosing agent used in the sclerotherapy treatment of varicose veins of the legs and esophagus." | 1.30 | Effectiveness of ethanolamine oleate as a pleural sclerosing agent in rabbits. ( Carmo, AO; Light, RW; Marchi, E; Silva, LM; Teixeira, LR; Vargas, FS, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Yagi, H | 1 |
| Nakayama-Imaohji, H | 1 |
| Nariya, H | 1 |
| Tada, A | 1 |
| Yamasaki, H | 1 |
| Ugai, H | 1 |
| Elahi, M | 1 |
| Ono, T | 1 |
| Kuwahara, T | 1 |
| Hinder, LM | 1 |
| Sas, KM | 1 |
| O'Brien, PD | 1 |
| Backus, C | 1 |
| Kayampilly, P | 1 |
| Hayes, JM | 1 |
| Lin, CM | 1 |
| Zhang, H | 1 |
| Shanmugam, S | 1 |
| Rumora, AE | 1 |
| Abcouwer, SF | 1 |
| Brosius, FC | 1 |
| Pennathur, S | 1 |
| Feldman, EL | 1 |
| Rai, H | 1 |
| Dhaneshwar, SS | 1 |
| Kamijo, Y | 1 |
| Hayashi, I | 1 |
| Ide, A | 1 |
| Yoshimura, K | 1 |
| Soma, K | 1 |
| Majima, M | 1 |
| Kelly, RF | 1 |
| Lamont, KT | 1 |
| Somers, S | 1 |
| Hacking, D | 1 |
| Lacerda, L | 1 |
| Thomas, P | 1 |
| Opie, LH | 1 |
| Lecour, S | 1 |
| Seo, JA | 1 |
| Bae, IH | 1 |
| Jang, WH | 1 |
| Kim, JH | 1 |
| Bak, SY | 1 |
| Han, SH | 1 |
| Park, YH | 1 |
| Lim, KM | 1 |
| Smart, SC | 1 |
| Fox, GB | 1 |
| Allen, KL | 1 |
| Swanson, AG | 1 |
| Newman, MJ | 1 |
| Swayne, GT | 1 |
| Clark, JB | 1 |
| Sales, KD | 1 |
| Williams, SC | 1 |
| Pavlov, VA | 1 |
| Teixeira, LR | 1 |
| Vargas, FS | 1 |
| Carmo, AO | 1 |
| Silva, LM | 1 |
| Marchi, E | 1 |
| Light, RW | 1 |
| Rajgopal, C | 1 |
| Lessels, A | 1 |
| Palmer, KR | 1 |
11 other studies available for ethanolamine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Ethanolamine utilization supports Clostridium perfringens growth in infected tissues.
Topics: Animals; Bacterial Toxins; Clostridium perfringens; Disease Models, Animal; Ethanolamine; Foodborne | 2018 |
Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopa | 2019 |
Amide-linked Ethanolamine Conjugate of Gemfibrozil as a Profound HDL Enhancer: Design, Synthesis, Pharmacological Screening and Docking Study.
Topics: Amides; Animals; Cholesterol, HDL; Disease Models, Animal; Ethanolamine; Gemfibrozil; Humans; Hyperl | 2015 |
Effects of inhaled monoethanolamine on bronchoconstriction.
Topics: Aerosols; Air Pollutants, Occupational; Airway Obstruction; Airway Resistance; Animals; Asthma; Atro | 2009 |
Ethanolamine is a novel STAT-3 dependent cardioprotective agent.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Cardiovascular Agents; Disease Models, Animal; Dos | 2010 |
Hydrogen peroxide and monoethanolamine are the key causative ingredients for hair dye-induced dermatitis and hair loss.
Topics: Alopecia; Animals; Cell Line; Cell Survival; Dermatitis, Contact; Disease Models, Animal; Drug Thera | 2012 |
Identification of ethanolamine in rat and gerbil brain tissue extracts by NMR spectroscopy.
Topics: Animals; Brain Chemistry; Brain Ischemia; Disease Models, Animal; Ethanolamine; Ethanolamines; Gerbi | 1994 |
[Different sensitivity biochemical mechanisms to mycobacterium tuberculosis of guinea pigs and rats].
Topics: Amino Acids; Animals; Disease Models, Animal; Disease Susceptibility; Ethanolamine; Ethanolamines; G | 1998 |
Effectiveness of ethanolamine oleate as a pleural sclerosing agent in rabbits.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanolamin | 1998 |
Mechanism of action of injection therapy for bleeding peptic ulcer.
Topics: Animals; Bleeding Time; Disease Models, Animal; Epinephrine; Ethanolamine; Ethanolamines; Gastric Mu | 1992 |